Global · 1 view
Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough
Hong Kong biotech entrepreneur Ricky Chiu Yin-to is seeking to make cervical cancer screening easier through urine-based HPV testing, using sample-concentration technology developed by his company.
AI Summary
Hong Kong biotech entrepreneur Ricky Chiu Yin‑to is developing a urine‑based HPV test to simplify cervical cancer screening, leveraging sample‑concentration technology created by his firm Phase Scientific. The company previously gained recognition during the Covid‑19 pandemic for its rapid antigen test, Indicaid.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Global
Continue reading recent Global coverage
- US justice department investigating TV networks over Trump pool coverageContinue reading
- New HK$122 million lifeguard outsourcing contract sparks public spending concernsContinue reading
- World condemns deadly Houthi attack on Saudi Arabia’s Riyadh airportContinue reading
- More support needed for ethnic minority children with special needs, charity saysContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow